DXCM
$81.68
Revenue | $1157.1Mn |
Net Profits | $179.8Mn |
Net Profit Margins | 15.54% |
PE Ratio | 57.51 |
Dexcom, Inc.’s revenue jumped 15.21% since last year same period to $1157.1Mn in the Q2 2025. On a quarterly growth basis, Dexcom, Inc. has generated 11.69% jump in its revenue since last 3-months.
Dexcom, Inc.’s net profit jumped 25.3% since last year same period to $179.8Mn in the Q2 2025. On a quarterly growth basis, Dexcom, Inc. has generated 70.59% jump in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin jumped 8.75% since last year same period to 15.54% in the Q2 2025. On a quarterly growth basis, Dexcom, Inc. has generated 52.73% jump in its net profit margins since last 3-months.
Dexcom, Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 57.51.
EPS Estimate Current Quarter | 0.57 |
EPS Estimate Current Year | 0.57 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.57 - a 28.36% jump from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.57.
Earning Per Share (EPS) | 0 |
Dexcom, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Dexcom, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-07-30 | 0.44 | 0.48 | 8.11% |
2025-10-23 | 0.57 | 0 | -100% |
2025-05-01 | 0.33 | 0.32 | -2.56% |